| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1496980A N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1150314C Immunity enhancing lactic acid bacteria |
| 05/19/2004 | CN1150204C Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150017C Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 05/19/2004 | CN1150016C Medicine for treating fever caused by lupus erythematosus immunological disease |
| 05/19/2004 | CN1150015C Medicine for treating leucocytopenia caused by lupus erythematosus |
| 05/19/2004 | CN1150014C Medicine for treating lupus erythematosus |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737434 Imidazole derivatives or their salts |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737051 Cell composition comprising macrophages and progenitor cells |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/13/2004 | WO2004040302A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 05/13/2004 | WO2004039981A1 Membrane protein originating in mast cells |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039834A2 Recombinant protein variants |
| 05/13/2004 | WO2004039806A1 Heterocyclic compounds |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039787A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/13/2004 | WO2004039782A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 05/13/2004 | WO2004039765A1 Use of urea variants as affinity ligands |
| 05/13/2004 | WO2004039763A1 Quaternary ammonium compounds |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004039409A2 Composition comprising activators of ik potassium channels and calcineurin antagonists and use thereof |
| 05/13/2004 | WO2004039408A1 Medicinal composition |
| 05/13/2004 | WO2004039395A1 Immunnoevasive agent for preventing graft rejection |
| 05/13/2004 | WO2004039376A1 Use of piperazine derivatives as ccr1 antagonists |
| 05/13/2004 | WO2004039368A1 Peroral preparation for prevention of or treatment for atopic dermatitis |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004017950A3 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 05/13/2004 | WO2004009542A3 Process for preparing certain pyrrolotriazine compounds |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2002085447A8 Microprojection array having a beneficial agent containing coating |
| 05/13/2004 | WO2002047703A8 Immune system stimulation |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | US20040093621 Trangenic cells which generate immunoglobulins for treatment of cancer and immunological diseases |
| 05/13/2004 | US20040092911 Ophthalmic drug delivery device |
| 05/13/2004 | US20040092907 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092717 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 05/13/2004 | US20040092709 Peptide mimics of the cytokine receptor common gamma chain and methods and compositions for making and using the same |
| 05/13/2004 | US20040092603 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 05/13/2004 | US20040092583 Treatment for inhibiting neoplastic lesions |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092529 Immunology moderator; Alzheimer's disease; anticancer agents; antiinflamamtory agents |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092500 Methods and therapeutic combinations for the treatment of demyelination |
| 05/13/2004 | US20040092499 Methods and therapeutic combinations for the treatment of autoimmune disorders |
| 05/13/2004 | US20040092468 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092445 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 05/13/2004 | US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091852 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 05/13/2004 | US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering |
| 05/13/2004 | US20040091539 A topical composition in the form of a solid stick comprising a corticosteroid, petrolatum, a wax, propylene glycol, and an emulsifier; an outer protective covering being constructed to prevent hand contact; anhydrous; skin disorders |
| 05/13/2004 | US20040091501 Immunosuppresor agent derived from morbillivirus |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | CA2503886A1 Recombinant protein variants |
| 05/13/2004 | CA2503770A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
| 05/13/2004 | CA2498261A1 Use of piperazine derivatives as ccr1 antagonists |
| 05/13/2004 | CA2498189A1 Quaternary ammonium compounds |
| 05/12/2004 | EP1418431A1 Nuclear pore protein Nup88 as a novel target |
| 05/12/2004 | EP1418174A2 Amorphous Ritonavir |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417236A2 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417226A1 Derp1 and proderp1 allergen derivatives |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |